• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高表达 CD133(+)CD44(+) 干细胞样细胞,其中包含 CD133(+)CD44(high) 转移亚群,存在于 HCT116 结肠癌细胞中。

Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.

机构信息

Department of Oncology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.

出版信息

Clin Exp Metastasis. 2011 Dec;28(8):751-63. doi: 10.1007/s10585-011-9407-7. Epub 2011 Jul 13.

DOI:10.1007/s10585-011-9407-7
PMID:21750907
Abstract

Stem-like cancer cells (SLCCs) are distinct cellular subpopulation in colon cancer that is essential for tumor maintenance. Previous studies indicated that SLCCs accounted for only a minor subset in a given cancer model. However, we found that SLCCs frequency varied among a panel of colon cancer cell lines, with HCT116 cells composed mainly of SLCCs, as demonstrated by colonosphere forming capability and CD133 expression. Indeed, flow cytometric analysis revealed more than 60% HCT116 cells co-expressed the putative SLCCs markers CD133 and CD44. Compared with non-CD133(+)CD44(+) cells, FACS sorted CD133(+)CD44(+) cells were undifferentiated, endowed with extensive self-renewal and epithelial lineage differentiation capacity in vitro. CD133(+)CD44(+) exhibited enhanced tumorigeneicity in NOD/SCID mice. One thousand CD133(+)CD44(+) cells initiated xenograft tumors efficiently (3/6) while 1 × 10(5) non-CD133(+)CD44(+) cells could only form palpable nodule with much slower growth rate (1/6). More interestingly, long-term cultured self-renewing CD133(+)CD44(+) cells enriched CD133(+)CD44(high) subset, which expressed epithelial to mesenchymal transition marker, were more invasive in vitro and responsible solely for liver metastasis in vivo. In conclusion, these data demonstrated for the first time that CD133(+)CD44(+) SLCCs were highly enriched in HCT116 cells and that metastatic SLCCs resided exclusively in a CD133(+)CD44(high) subpopulation.

摘要

肿瘤干细胞(SLCCs)是结肠癌中一种独特的细胞亚群,对于肿瘤的维持至关重要。先前的研究表明,SLCCs 在给定的癌症模型中仅占一小部分。然而,我们发现 SLCCs 的频率在一系列结肠癌细胞系中有所不同,HCT116 细胞主要由 SLCCs 组成,这可以通过其形成类器官的能力和 CD133 表达来证明。事实上,流式细胞术分析显示,超过 60%的 HCT116 细胞共同表达了假定的 SLCCs 标志物 CD133 和 CD44。与非 CD133(+)CD44(+)细胞相比,FACS 分选的 CD133(+)CD44(+)细胞未分化,具有广泛的自我更新和上皮谱系分化能力。CD133(+)CD44(+)在 NOD/SCID 小鼠中具有更强的致瘤性。1000 个 CD133(+)CD44(+)细胞能够有效地启动异种移植肿瘤(3/6),而 1×10(5)个非 CD133(+)CD44(+)细胞只能形成可触及的结节,生长速度较慢(1/6)。更有趣的是,长期培养的自我更新的 CD133(+)CD44(+)细胞富集了 CD133(+)CD44(high)亚群,该亚群表达上皮间质转化标志物,在体外具有更强的侵袭性,并且是体内肝转移的唯一原因。总之,这些数据首次表明,CD133(+)CD44(+) SLCCs 在 HCT116 细胞中高度富集,而转移性 SLCCs 仅存在于 CD133(+)CD44(high)亚群中。

相似文献

1
Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.高表达 CD133(+)CD44(+) 干细胞样细胞,其中包含 CD133(+)CD44(high) 转移亚群,存在于 HCT116 结肠癌细胞中。
Clin Exp Metastasis. 2011 Dec;28(8):751-63. doi: 10.1007/s10585-011-9407-7. Epub 2011 Jul 13.
2
Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.鉴定结肠癌中具有长期肿瘤起始能力的亚群细胞。
Biosci Rep. 2020 Aug 28;40(8). doi: 10.1042/BSR20200437.
3
Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?人前列腺癌细胞DU145中的癌干细胞样细胞:该细胞系的种子?
Cancer Biol Ther. 2007 May;6(5):763-8. doi: 10.4161/cbt.6.5.3996. Epub 2007 Feb 8.
4
CD133+CD44+ population efficiently enriches colon cancer initiating cells.CD133+CD44+细胞群能有效地富集结肠癌起始细胞。
Ann Surg Oncol. 2008 Oct;15(10):2927-33. doi: 10.1245/s10434-008-0074-0. Epub 2008 Jul 29.
5
CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients.CD133(+)CXCR4(+) 结肠癌细胞具有转移潜能,并预测患者预后不良。
BMC Med. 2012 Aug 7;10:85. doi: 10.1186/1741-7015-10-85.
6
CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers.CD133 和 CD44 在 GIST 中普遍过表达,并不代表癌症干细胞标志物。
Genes Chromosomes Cancer. 2012 Feb;51(2):186-95. doi: 10.1002/gcc.20942. Epub 2011 Nov 10.
7
Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.转移性结肠癌干细胞的表型亚群:基因组分析
Cancer Genomics Proteomics. 2009 Jan-Feb;6(1):19-29.
8
Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.CD44(高)/CD133(高)的HCT-116细胞在结肠癌肿瘤发生中的作用。
Oncotarget. 2016 Feb 16;7(7):7657-66. doi: 10.18632/oncotarget.7084.
9
Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.评估 CD44 和 CD133 作为结直肠癌的肿瘤干细胞标志物。
Oncol Rep. 2012 Oct;28(4):1301-8. doi: 10.3892/or.2012.1951. Epub 2012 Aug 6.
10
Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.表达 CD44 的非小细胞肺癌细胞富含干细胞样特性。
PLoS One. 2010 Nov 19;5(11):e14062. doi: 10.1371/journal.pone.0014062.

引用本文的文献

1
Enrichment of ornithine decarboxylase degron transduced colorectal cancer cells for extended application of cancer stem cell models.富含鸟氨酸脱羧酶降解结构域转导的结肠癌细胞,用于癌症干细胞模型的扩展应用。
Sci Rep. 2025 Jul 2;15(1):22886. doi: 10.1038/s41598-025-04277-w.
2
Charged multivesicular body protein 7 was identified as a prognostic biomarker correlated with metastasis in colorectal cancer.带电多囊泡体蛋白7被鉴定为与结直肠癌转移相关的预后生物标志物。
World J Gastrointest Oncol. 2025 Jun 15;17(6):105967. doi: 10.4251/wjgo.v17.i6.105967.
3
Prominosomes - a particular class of extracellular vesicles containing prominin-1/CD133?

本文引用的文献

1
New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells.新一代紫杉烷类 SB-T-1214 通过纯化的结肠肿瘤起始细胞诱导的 3D 癌症球体抑制干细胞相关基因表达。
Mol Cancer. 2010 Jul 14;9:192. doi: 10.1186/1476-4598-9-192.
2
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
3
A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer.
突起小体——一类含有prominin-1/CD133的特殊细胞外囊泡?
J Nanobiotechnology. 2025 Jan 29;23(1):61. doi: 10.1186/s12951-025-03102-w.
4
Targeted Therapy of Tumors and Cancer Stem Cells based on Oxidant-regulated Redox Pathway and its Mechanism.基于氧化剂调节的氧化还原途径的肿瘤及癌症干细胞靶向治疗及其机制
Curr Comput Aided Drug Des. 2025;21(4):425-440. doi: 10.2174/0115734099299174240522115944.
5
Multifunctional Liposomes Co-Modified with Ginsenoside Compound K and Hyaluronic Acid for Tumor-Targeted Therapy.人参皂苷Compound K和透明质酸共修饰的多功能脂质体用于肿瘤靶向治疗
Polymers (Basel). 2024 Feb 1;16(3):405. doi: 10.3390/polym16030405.
6
Cellular Effects of Selected Unsymmetrical Bisacridines on the Multicellular Tumor Spheroids of HCT116 Colon and A549 Lung Cancer Cells in Comparison to Monolayer Cultures.所选不对称双吖啶类化合物对 HCT116 结肠和 A549 肺癌多细胞肿瘤球与单层培养物的细胞效应比较。
Int J Mol Sci. 2023 Oct 30;24(21):15780. doi: 10.3390/ijms242115780.
7
Differences and Similarities between Colorectal Cancer Cells and Colorectal Cancer Stem Cells: Molecular Insights and Implications.结直肠癌细胞与结直肠癌干细胞之间的异同:分子见解与启示
ACS Omega. 2023 Aug 9;8(33):30145-30157. doi: 10.1021/acsomega.3c02681. eCollection 2023 Aug 22.
8
Long noncoding RNA 01534 maintains cancer stemness by downregulating endoplasmic reticulum stress response in colorectal cancer.长链非编码RNA 01534通过下调内质网应激反应维持结直肠癌的癌干性。
Ann Gastroenterol Surg. 2022 Dec 29;7(3):458-470. doi: 10.1002/ags3.12649. eCollection 2023 May.
9
Therapeutic vulnerabilities of cancer stem cells and effects of natural products.癌症干细胞的治疗弱点和天然产物的作用。
Nat Prod Rep. 2023 Aug 16;40(8):1432-1456. doi: 10.1039/d3np00002h.
10
Assessing Putative Markers of Colorectal Cancer Stem Cells: From Colonoscopy to Gene Expression Profiling.评估结直肠癌干细胞的假定标志物:从结肠镜检查到基因表达谱分析。
Diagnostics (Basel). 2022 Sep 21;12(10):2280. doi: 10.3390/diagnostics12102280.
人结直肠癌中具有转移能力的 CD26+癌症干细胞亚群。
Cell Stem Cell. 2010 Jun 4;6(6):603-15. doi: 10.1016/j.stem.2010.04.001.
4
A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.胶质母细胞瘤中自我更新肿瘤起始细胞类型的层次结构。
Cancer Cell. 2010 Apr 13;17(4):362-75. doi: 10.1016/j.ccr.2009.12.049.
5
Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery.扩增具有干细胞特性的 CD133(+)结肠癌培养物,以发现癌症干细胞靶标。
Br J Cancer. 2010 Apr 13;102(8):1265-75. doi: 10.1038/sj.bjc.6605610. Epub 2010 Mar 23.
6
Complex display of putative tumor stem cell markers in the NCI60 tumor cell line panel.NCI60 肿瘤细胞系panel 中推测的肿瘤干细胞标志物的复杂表达。
Stem Cells. 2010 Apr;28(4):649-60. doi: 10.1002/stem.324.
7
Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma.胰腺腺癌中具有间充质特征的肿瘤细胞的预后意义。
J Natl Cancer Inst. 2010 Mar 3;102(5):340-51. doi: 10.1093/jnci/djp535. Epub 2010 Feb 17.
8
Cancer stem cells from colorectal cancer-derived cell lines.结直肠癌细胞系中的癌症干细胞。
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3722-7. doi: 10.1073/pnas.0915135107. Epub 2010 Feb 2.
9
Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content.乳腺癌的生物学和分子异质性与其癌症干细胞含量相关。
Cell. 2010 Jan 8;140(1):62-73. doi: 10.1016/j.cell.2009.12.007.
10
The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor.肝癌患者原发和复发性肿瘤中肿瘤起始细胞的特性。
Carcinogenesis. 2010 Feb;31(2):167-74. doi: 10.1093/carcin/bgp232. Epub 2009 Nov 6.